Literature DB >> 18791688

Correlation analysis between the expression of P21WAF1/CIP1, P16 proteins and human glioma.

Tao Song1, Jun Wu, Fang Fang, Fanghua Chen, Lei Huo, Mingyu Zhang, Lei Wu, Zhiyong Zhai, Liang Yang, Jiesheng Fang.   

Abstract

AIM: Glioma is the most common neoplasm of the brain. Unfortunately, surgical cure of it is practically impossible and clinical course is primarily determined by the biological behaviour of the tumour cells. The purpose of this study was to investigate the correlation between the expression levels of P21WAF1/CIP1, P16 proteins and the grading of glioma.
METHODS: T98G human glioma cell line, normal human astrocyte (HA) cell line, tumour tissue samples from 70 patients suffering from glioma and normal brain tissues from 20 cases with brain contusion were investigated. The expression levels of P21WAF1/CIP1 and P16 proteins were detected using SABC immunohistochemical staining and semi-quantitive reverse transcriptase polymerase chain reaction (RT-PCR) assay. Then, the correlation of the two markers' expression with glioma grading of patients was analysed.
RESULTS: The expression levels of P21WAF1/CIP1 and P16 proteins in the T98G cell line were much lower than that in the HA cell line. Their positive expression rates in glioma tissues were 55.71% and 42.86% respectively, and a significant increase was observed in normal brain tissues (p = 0.012, 0.008). Combined with the result of semi-quantitive RT-PCR, we could demonstrate that the expression intensity of P21WAF1/CIP1 and P16 decreased with the glioma grade increase. Co-expression of them was also found in glioma and normal brain tissues. Furthermore, there was a negative correlation between the two markers' expression and glioma grading of patients (rs = -0.68, -0.56).
CONCLUSIONS: The positive expression rate and co-expression rate of P21WAF1/CIP1 and P16 proteins could reflect the malignant grade of glioma to some extent, and they can be considered as a sensitive index for glioma grading.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791688     DOI: 10.1007/s10238-008-0172-0

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  20 in total

Review 1.  Malignant glioma: neuropathology and neurobiology.

Authors:  Matthias Preusser; Christine Haberler; Johannes A Hainfellner
Journal:  Wien Med Wochenschr       Date:  2006-06

2.  Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival.

Authors:  David A Hilton; Mark Penney; Barry Evans; Hilary Sanders; Seth Love
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

3.  Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.

Authors:  P Ghaneh; W Greenhalf; M Humphreys; D Wilson; L Zumstein; N R Lemoine; J P Neoptolemos
Journal:  Gene Ther       Date:  2001-02       Impact factor: 5.250

4.  Radiosensitivity and TP 53, EGFR amplification and LOH10 analysis of primary glioma cell cultures.

Authors:  Bärbel Gerlach; Anna H Harder; Theo J M Hulsebos; Sieger Leenstra; Berend J Slotman; W Peter Vandertop; Karl-Axel Hartmann; Peter Sminia
Journal:  Strahlenther Onkol       Date:  2002-09       Impact factor: 3.621

5.  Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.

Authors:  A Besson; V W Yong
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest.

Authors:  K S Hung; C Y Hong; J Lee; S K Lin; S C Huang; T M Wang; V Tse; G D Sliverberg; S C Weng; M Hsiao
Journal:  Biochem Biophys Res Commun       Date:  2000-03-24       Impact factor: 3.575

Review 7.  Molecular biology of gliomas.

Authors:  Andrew B Lassman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 8.  Mitogenic signaling cascades in glial tumors.

Authors:  Gurpreet S Kapoor; Donald M O'Rourke
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

9.  Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.

Authors:  P Korkolopoulou; K Kouzelis; P Christodoulou; A Papanikolaou; E Thomas-Tsagli
Journal:  Acta Neuropathol       Date:  1998-06       Impact factor: 17.088

10.  Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas.

Authors:  Stella M Ranuncolo; Mirta Varela; Ana Morandi; José Lastiri; Silvia Christiansen; Elisa Bal de Kier Joffé; María G Pallotta; Lydia Puricelli
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

View more
  1 in total

1.  Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.

Authors:  Xia Xue; Xian-Jun Qu; Zu-Hua Gao; Cui-Cui Sun; Hui-Ping Liu; Cui-Rong Zhao; Yan-Na Cheng; Hong-Xiang Lou
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.